SINO BIOENERGY CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0004 USD | -50.00% |
|
-.--% | -.--% |
| 2013 | Sino Bioenergy Corp. Announces Management Changes | CI |
| 2013 | Sino Bioenergy Corp. cancelled the acquisition of 51% in Noble Success Limited. | CI |
Valuation
| Fiscal Period: December | 2022 |
|---|---|
| Capitalization 1 | 2.136 |
| Enterprise Value (EV) 1 | 2.16 |
| P/E ratio | -6.37 x |
| Yield | - |
| Capitalization / Revenue | - |
| EV / Revenue | - |
| EV / EBITDA | - |
| EV / FCF | - |
| FCF Yield | - |
| Price to Book | -6.37 x |
| Nbr of stocks (in thousands) | 711,916 |
| Reference price 2 | 0.003000 |
| Announcement Date | 2/1/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 |
|---|---|
| Net sales | - |
| EBITDA | - |
| EBIT 1 | -0.0167 |
| Operating Margin | - |
| Earnings before Tax (EBT) 1 | -0.0242 |
| Net income 1 | -0.0242 |
| Net margin | - |
| EPS 2 | -0.000471 |
| Free Cash Flow | - |
| FCF margin | - |
| FCF Conversion (EBITDA) | - |
| FCF Conversion (Net income) | - |
| Dividend per Share | - |
| Announcement Date | 2/1/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 |
|---|---|
| Net Debt 1 | 0.02 |
| Net Cash position 1 | - |
| Leverage (Debt/EBITDA) | - |
| Free Cash Flow | - |
| ROE (net income / shareholders' equity) | - |
| ROA (Net income/ Total Assets) | - |
| Assets 1 | - |
| Book Value Per Share 2 | -0 |
| Cash Flow per Share 2 | 0 |
| Capex | - |
| Capex / Sales | - |
| Announcement Date | 2/1/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 20.5K | |
| +8.23% | 1.93B | |
| -.--% | 209M | |
| -0.87% | 205M |
- Stock Market
- Equities
- SFBE Stock
- Financials Sino Bioenergy Corp.
